rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Voveran

Rediff.com  »  News  »   Voveran

  News for Voveran

  • Business

Novartis' Voveran regains top position

Voveran, Novartis India's flagship pain killer medicine, has become the largest selling domestic drug with sales of more than Rs 11 crore (Rs 110 million) in March 2008, displacing Pfizer India's......

NPPA slaps Rs 300-crore penalty on Novartis

Drug major Novartis has been slapped with a Rs 300-crore (Rs 3 billion) penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine. The Swiss......

Markets end higher; Sep inflation, RIL Q2 eyed

Benchmark share indices staged a recovery in late trades, amid firm European cues, helped by a rebound in financials while IT shares gained post upbeat July-September earnings from Infosys. The......

Old is gold: Heritage pharma brands take the lead

At a time when pharmaceutical companies are investing billions of dollars to develop new and path-breaking medicines, it is the old and heritage brands that continue to dominate the market. Sales......

Novartis may revise open offer price

Switzerland-based, Novartis AG, the parent company of Novartis India, is likely to revise its open offer price to buy back an additional stake of up to 39 per cent of equity to increase its......
  Web results for Voveran
IPM clocks Rs 8446 crores in April 2016

12 therapies have outgrown the IPM growth The Indian Pharma Market (IPM) has clocked Rs 8446 crores in April 2016 and has grown at 3.5 per cent.... ...

http://www.financialexpress.com/pharma/market-pharma/indian-pharma-market-clocks-rs-8446-crores-in-april-2016/273154/
IPM registers Rs 8449 crs in May 2016

The Odisha market grew the highest followed by Mumbai City Market and Karnataka The Indian Pharmaceutical Market clocked Rs 8449 crores in May... ...

http://www.financialexpress.com/pharma/market-pharma/the-indian-pharmaceutical-market-registers-rs-8449-crs-in-may-2016/301902/
Delhi HC seeks Centre, Novartis response on Troikaa Pharma petition for ban on painkiller injection Diclofenac

Voveran 1ml and Aquadol are in competition with Troikaa's own painkiller injection Dynapar AQ since their launch in 2013. (Photo: PTI) The Delhi... ...

http://www.financialexpress.com/article/economy/high-court-seeks-centres-response-on-plea-for-ban-on-painkiller-jab/261473
Indian pharma Co. may sue drug controller over safety of Novartis painkiller

NEW DELHI: Gujarat-based Troikaa Pharmaceuticals, an Indian pharmaceutical company, may sue the government for not putting an end to sales of a... ...

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-co-may-sue-drug-controller-over-safety-of-novartis-painkiller/articleshow/52347842.cms

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z